Metropolitan Life Insurance Company (MetLife)’s EQRx, Inc. Common Stock EQRX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EQRX Stock Details EQRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,777	Closed	-$39.5K	–	2414
2023 Q3	$39.5K	Hold	17,777	–	–	﹤0.01%	1536
2023 Q2	$33.1K	Buy	17,777 +6,382	+56%	+$11.4K	﹤0.01%	1664
2023 Q1	$22.1K	Sell	11,395 -1,235	-10%	-$2.81K	﹤0.01%	1839
2022 Q4	$31.1K	Hold	12,630	–	–	﹤0.01%	1769
2022 Q3	$62.5K	Buy	12,630 +3,963	+46%	+$20K	﹤0.01%	1304
2022 Q2	$40.6K	Buy	+8,667	New	+$39.1K	﹤0.01%	1629

Metropolitan Life Insurance Company (MetLife)'s EQRX Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of EQRx, Inc. Common Stock (EQRX) in Q4 2023, closing a stake of 17,777 shares — an estimated $39.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EQRX in Q2 2022 and held it in 6 quarters. The position peaked at $62.5K in Q3 2022. 0 funds tracked by Wall St. Rank hold EQRX as of Q4 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining EQRx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 17,777 EQRx, Inc. Common Stock shares in Q4 2023, an estimated $39.5K.
Metropolitan Life Insurance Company (MetLife) first reported a position in EQRx, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Metropolitan Life Insurance Company (MetLife)'s EQRx, Inc. Common Stock position peaked at $62.5K in Q3 2022.
0 funds tracked by Wall St. Rank held EQRx, Inc. Common Stock as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.